Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents
Author(s) -
John Scott Baird
Publication year - 2022
Publication title -
international journal of inflammation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.106
H-Index - 33
eISSN - 2090-8040
pISSN - 2042-0099
DOI - 10.1155/2022/6207417
Subject(s) - medicine , lymphocytopenia , hemophagocytic lymphohistiocytosis , cytokine storm , procalcitonin , systemic inflammatory response syndrome , organ dysfunction , macrophage activation syndrome , systemic inflammation , ferritin , multiple organ dysfunction syndrome , sepsis , inflammation , pediatrics , disease , covid-19 , lymphocyte , infectious disease (medical specialty)
. Recurrent extreme hyperferritinemia (ferritin >10,000 ng/mL) was noted in 4 critically ill adolescents prior to death, though this association has not previously been described. Methods. A retrospective review of the medical records of 4 critically ill adolescents with recurrent extreme hyperferritinemia and systemic inflammation was performed to identify additional common epidemiologic factors. Results. Systemic inflammation was characterized as cytokine storm syndrome in 2 patients and hemophagocytic lymphohistiocytosis in 2 patients. Episodes of extreme hyperferritinemia were noted on at least 2 different dates in all patients; these episodes (n = 10) were separated by an interval of 2 weeks to several months and were usually (in 8 of 10 episodes) associated with the onset or worsening of multiple organ dysfunction syndrome. Death occurred within 2 weeks of the onset of an episode of recurrent extreme hyperferritinemia. Lymphocytopenia and cachexia were noted in all patients. Conclusions. Recurrent extreme hyperferritinemia—often with multiple organ dysfunction syndrome—was noted in 4 adolescents with systemic inflammation who did not survive their critical illness. Recurrent extreme hyperferritinemia may be a novel biomarker of increased mortality in patients with the syndrome of persistent inflammation, immunosuppression, and catabolism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom